This sustains results without continued dose increases
Lower doses may still activate GLP-1 receptors, but appetite suppression tends to scale with dose intensity
Preliminary data suggest that -Hydroxy--methylbutyrate may attenuate lean mass loss during caloric restriction [54]
Parkinsons disease drug therapies in the clinical trial pipeline: 2022 update
arthralgia incidence in trials is generally similar to placebo Rapid weight loss from GLP-1 treatment may alter biomechanical loading on joints, causing temporary adjustment-related discomfort Patients prescribed GLP-1 medications often have type 2 diabetes or obesity, conditions independently associated with increased osteoarthritis rates Seek medical advice for severe, worsening, or persistent joint pain, or if accompanied by swelling, redness, warmth, or systemic symptoms Report suspected medication side effects through the MHRA Yellow Card scheme to support ongoing safety monitoring Table of Contents Understanding GLP-1 Medications and Their Common Side Effects GLP-1 receptor agonists, including semaglutide (Ozempic, Wegovy) and liraglutide (Victoza, Saxenda), most commonly cause gastrointestinal side effects such as nausea, vomiting, and diarrhoea
Drug interactions and side effects of Semaglutide In studying the effects of semaglutide treatment on the pharmacokinetics metformin, warfarin, atorvastatin and digoxin, it was found that this GLP-1 analog did not affect such properties to a clinically relevant degree (Hausner et al., 2017)
